Triumph Financial Announces Schedule for Second Quarter 2024 Earnings Release and Conference Call
05 juil. 2024 09h05 HE
|
Triumph Financial, Inc.
DALLAS, July 05, 2024 (GLOBE NEWSWIRE) -- Triumph Financial, Inc. (Nasdaq: TFIN) today announced that it expects to release its second quarter financial results and management commentary after the...
Provident Financial Services, Inc. Schedules Second Quarter Earnings Conference Call
01 juil. 2024 08h00 HE
|
Provident Financial Services, Inc.
ISELIN, N.J., July 01, 2024 (GLOBE NEWSWIRE) -- Provident Financial Services, Inc. (NYSE: PFS) announced that it expects to release financial results for the quarter ended June 30, 2024 on Thursday,...
Beneficient Announces Fourth Quarter and Full Year Fiscal 2024 Earnings Release and Webcast
01 juil. 2024 07h00 HE
|
Beneficient
Beneficient (NASDAQ: BENF) will release its Fiscal 2024 financial results on Tuesday, July 2, 2024 and will host a webcast at 8:30 a.m.
Retail Opportunity Investments Corp. Schedules Second Quarter Earnings Release and Conference Call
11 juin 2024 09h00 HE
|
Retail Opportunity Investments Corp.
Retail Opportunity Investments Corp. Schedules Second Quarter Earnings Release and Conference Call
Updated Time: Agios to Present at the Goldman Sachs 45th Annual Global Healthcare Conference on June 10, 2024 at 8:40 am ET
06 juin 2024 09h00 HE
|
Agios Pharmaceuticals, Inc.
CAMBRIDGE, Mass., June 06, 2024 (GLOBE NEWSWIRE) -- Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a leader in cellular metabolism and PK activation pioneering therapies for rare diseases, today...
Alterity Therapeutics to Host Webcast Today on New Data from the bioMUSE Natural History Study
29 mai 2024 19h21 HE
|
ALTERITY THERAPEUTICS LIMITED
- New bioMUSE Data Informs ATH434-202 Study Endpoints - - Webcast to Include Key Opinion Leader, Daniel Claassen, M.D., M.S., Vanderbilt University - MELBOURNE, Australia and SAN FRANCISCO, May ...
Arbutus to Participate in Jefferies Global Healthcare Conference
29 mai 2024 07h30 HE
|
Arbutus Biopharma Corporation
WARMINSTER, Pa., May 29, 2024 (GLOBE NEWSWIRE) -- Arbutus Biopharma Corporation (Nasdaq: ABUS), a clinical-stage biopharmaceutical company leveraging its extensive virology expertise to develop a...
UMH PROPERTIES, INC. TO PARTICIPATE IN NAREIT’S REITWEEK: 2024 INVESTOR CONFERENCE
28 mai 2024 16h07 HE
|
UMH Properties, Inc.
FREEHOLD, NJ, May 28, 2024 (GLOBE NEWSWIRE) -- UMH Properties, Inc. (NYSE:UMH) (TASE:UMH), today announced that the Company will participate in Nareit’s REITweek: 2024 Investor Conference, to be...
Micron Technology to Report Fiscal Third Quarter Results on June 26, 2024
28 mai 2024 16h01 HE
|
Micron Technology, Inc.
BOISE, Idaho, May 28, 2024 (GLOBE NEWSWIRE) -- Micron Technology, Inc. (Nasdaq: MU), announced today that it will hold its fiscal third quarter earnings conference call on Wednesday, June 26, 2024,...
Optinose to Present at the H.C. Wainwright 2nd Annual BioConnect Investor Conference at NASDAQ
17 mai 2024 12h00 HE
|
Optinose, Inc.
YARDLEY, Pa., May 17, 2024 (GLOBE NEWSWIRE) -- Optinose (NASDAQ:OPTN), a pharmaceutical company focused on patients treated by ear, nose and throat (ENT) and allergy specialists, today announced...